SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ellen P. Hart, Eve M. Dumas, Erik W. Zwet, Karin Hiele, Caroline K. Jurgens, Huub A. M. Middelkoop, J. Gert Dijk, Raymund A. C. Roos, Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease, Journal of Neuropsychology, 2015, 9, 1
  2. 2
    Anthony WS Chan, Yan Xu, Jie Jiang, Tayeb Rahim, Dongming Zhao, Jannet Kocerha, Tim Chi, Sean Moran, Heidi Engelhardt, Katherine Larkin, Adam Neumann, Haiying Cheng, Chunxia Li, Katie Nelson, Heather Banta, Stuart M Zola, Francois Villinger, Jinjing Yang, Claudia M Testa, Hui Mao, Xiaodong Zhang, Jocelyne Bachevalier, A two years longitudinal study of a transgenic Huntington disease monkey, BMC Neuroscience, 2014, 15, 1, 36

    CrossRef

  3. 3
    Christopher A. Ross, Elizabeth H. Aylward, Edward J. Wild, Douglas R. Langbehn, Jeffrey D. Long, John H. Warner, Rachael I. Scahill, Blair R. Leavitt, Julie C. Stout, Jane S. Paulsen, Ralf Reilmann, Paul G. Unschuld, Alice Wexler, Russell L. Margolis, Sarah J. Tabrizi, Huntington disease: natural history, biomarkers and prospects for therapeutics, Nature Reviews Neurology, 2014, 10, 4, 204

    CrossRef

  4. 4
    X. Sun, L. O. Marque, Z. Cordner, J. L. Pruitt, M. Bhat, P. P. Li, G. Kannan, E. E. Ladenheim, T. H. Moran, R. L. Margolis, D. D. Rudnicki, Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity, Human Molecular Genetics, 2014, 23, 23, 6302

    CrossRef

  5. 5
    Adrienne Withall, Brian Draper, Katrin Seeher, Henry Brodaty, The prevalence and causes of younger onset dementia in Eastern Sydney, Australia, International Psychogeriatrics, 2014, 26, 12, 1955

    CrossRef

  6. 6
    Yvette M. Bordelon, Clinical Neurogenetics, Neurologic Clinics, 2013, 31, 4, 1085

    CrossRef

  7. 7
    A. W. S. Chan, Progress and Prospects for Genetic Modification of Nonhuman Primate Models in Biomedical Research, ILAR Journal, 2013, 54, 2, 211

    CrossRef

  8. 8
    Ondrej Bezdicek, Veronika Majerova, Marek Novak, Tomas Nikolai, Evzen Ruzicka, Jan Roth, Validity of the Montreal Cognitive Assessment in the Detection of Cognitive Dysfunction in Huntington's Disease, Applied Neuropsychology, 2013, 20, 1, 33

    CrossRef

  9. 9
    Michele Poletti, Ivan Enrici, Mauro Adenzato, Cognitive and affective Theory of Mind in neurodegenerative diseases: Neuropsychological, neuroanatomical and neurochemical levels, Neuroscience & Biobehavioral Reviews, 2012, 36, 9, 2147

    CrossRef

  10. 10
    Ainhi D. Ha, Victor S.C. Fung, Huntingtonʼs disease, Current Opinion in Neurology, 2012, 25, 4, 491

    CrossRef

  11. 11
    Jane S. Paulsen, Cognitive Impairment in Huntington Disease: Diagnosis and Treatment, Current Neurology and Neuroscience Reports, 2011, 11, 5, 474

    CrossRef

  12. 12
    Andrew Feigin, Pridopidine in treatment of Huntington's disease: beyond chorea?, The Lancet Neurology, 2011, 10, 12, 1036

    CrossRef

  13. 13
    Ainhi Ha, Joseph Jankovic, Huntington Disease and Other Genetic Choreas,